Purpose of the development: It is used for the examination and treatment of hyperplastic processes of the reproductive system in women of different age groups.

Recommended application field: Medicine, obstetrics and gynecology, pediatric gynecology.

Advantages over analogues: For the period 2004-2005, the incidence of uterine fibroids increased from 12.9% to 18.4%, and tumor formations opuhaley ovaries from 11% to 25%. Hyperplasia of the reproductive system in co-developing form. Hyperplasia of mammary glands are set at 17.1% of women of different ages, and prevailed glandular-fibrous form of mastitis. The algorithm of the phase of treatment patients with uterine fibroids. Hormonal contraceptive therapy has a protective effect on the development of benign tumors and breast cancer. Causes inhibition of growth of uterine fibroids, and reduces the frequency of production organoudalyayuschih operations that cause disability of women of different age groups.

The development stage readiness: Introduced in production

Description of the development:
()
The incidence and prevalence of hyperplastic processes of the female reproductive system. The state of the target organs in hyperplastic and developed best practices for diagnosis and treatment. Compared to previous years, using modern diagnostic technology hyperplastic processes of the reproductive system: laparskopiya, hysteroscopy, Doppler blood vessels of the pelvic organs, colposcopy, mammography, and others in the treatment of hyperplastic processes of the reproductive system used conservative methods of treatment. In the case of surgical techniques were of organ surgery. Approved by the accounting board Tajik Research Institute of Obstetrics, Gynecology and Pediatrics Department of Health of the Republic of Tajikistan.

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Tajikistan

For additional information turn to:
E-mail: gal@uintei.kiev.ua